ERBB2 and colorectal carcinoma: Regarding the data on co-occurring MSI/MMR-affected function and mutations in HER2/ERBB3, the recent study published by Qiu and colleagues reported that cases of HER2-mutated CRC are more likely to harbor an MSI-high status in comparison with the HER2 amplified ones [36].